CK Life Sciences (00775) issued a profit warning, expecting a net loss attributable to shareholders of approximately 1.266 billion yuan for the year, compared to a profit in the same period last year.

CK LIFE SCIENCES (00775) announced that the group is expected to incur a loss attributable to shareholders of 126.6 million yuan for the year ending December 31, 2024 (reporting year), compared to a profit attributable to shareholders of 17.3 million yuan for the year ending December 31, 2023. The change from profit to loss is attributed to the company's decision to increase research and development investment, as well as a decrease in the fair value of the vineyard portfolio. Overall, the group's operations remained stable during the reporting year and up to the date of this announcement.